Anagrelide hydrochloride
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131620This classification denotes an antiplatelet agent with the molecular formula C10H7Cl2N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VNS4435G39, chemically known as 6,7-dichloro-1,5-dihydroimidazo(2,1-b)-quinazolin-2(3h)-one monohydrochloride but generally known as anagrelide hydrochloride, which bears US NIH Compound Identifier 42786. European Medicines Agency schedules Anagrelide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00523MIG. Most nations schedule anagrelide hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, ANAGRELIDE HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Anagrelide hydrochloride bears US NLM identifiers UMLS ID C0771907 and NCI Concept Code C28826. SMILES: C1C2=C(C=CC(=C2CL)CL)NC3=NC(=O)CN31.CL.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.